Increase of arterial thrombosis parameters in chronic Helicobacter pylori infection in mice

Thrombosis Research

Volumn 108, Issue 4, 2002, Pages 245-248

  Aguejouf, O ^a   Mayo, K ^a   Monteiro, L ^a   Doutremepuich, F ^a   Doutremepuich, C ^a   Megraud, F ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Embolization; Fibrinogen; Helicobacter pylori; Inflammation; Laser; Thrombus

Indexed keywords

FIBRINOGEN;

ANIMAL MODEL; ANIMAL TESTING ALTERNATIVE; ANIMAL TISSUE; ARGON LASER; ARTERY INJURY; ARTERY THROMBOSIS; ARTICLE; ARTIFICIAL EMBOLISM; BLOOD FLOW; BLOOD VESSEL INJURY; CAMERA; CELL COUNT; CHRONIC DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DYNAMICS; EMBOLISM; HELICOBACTER INFECTION; HELICOBACTER PYLORI; ISCHEMIC HEART DISEASE; MESENTERIC ARTERY; MOUSE; MOUSE STRAIN; NONHUMAN; PARAMETER; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOGENESIS; TIME PERCEPTION; VASCULAR LESION; VIDEORECORDING;

EID: 0037176133     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(03)00006-9     Document Type: Article

References (26)

1. Murray C.J.L., Lopez A.D. Mortality by cause for eight regions of the world: global burden of disease study. Lancet. 349:1997;1269-1276.
2. Ridker P.M. Fibrinolytic and inflammatory markers for arterial occlusion: the evolving epidemiology of thrombosis and hemostasis. Thromb. Haemost. 78:1997;53-59.
3. Bainton D., Jones G.R., Hole D. Influenza and ischaemic heart disease - a possible trigger for acute myocardial infarction? Int. J. Epidemiol. 7:1978;231-239.
4. Mattila K.J., Nieminen M.S., Valtonen V.V., Rasi V.P., Kesaniemi Y.A., Syrjala S.L.et al. Association between dental health and acute myocardial infarction. BMJ. 298(6676):1989;779-781.
5. Gurfinkel E., Bozovich G., Daroca A., Beck E., Mautner B. Randomized trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. Lancet. 350:1997;404-407.
6. Gupta S., Leatham E.W., Carrington D., Mendall M.A., Kaski J.C., Camm J. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation. 96:1997;404-407.
7. Yarnell J.W., Baker I.A., Sweetman P.M., Bainton D., O'Brien J.R., Whitehead P.J.et al. Fibrinogen viscosity and white blood cell count are major risk factors for ischaemic heart disease. Circulation. 83:1991;836-844.
8. Siess W. Molecular mechanisms of platelet activation. Physiol. Rev. 69:1989;58-178.
9. Vesvres M.H., Doutremepuich F., Lalanne M.C., Doutremepuich C. Effect of aspirin on embolization in an arterial model of laser-induced thrombus formation. Haemostasis. 23:1993;8-12.
10. Doutremepuich F., Aguejouf O., Imbault P., Azougagh Oualane F., Doutremepuich C. Effect of the low molecular weight heparin/non-steroidal anti-inflammatory drugs association in an experimental thrombosis induced by laser. Thromb. Res. 77:1995;319-331.
11. Aguejouf O., Doutremepuich F., Azougagh Oualane F., Doutremepuich C. Thrombogenicity of ionic and non-ionic contrast tested in a laser induced rat thrombosis model. Thromb. Res. 77:1995;259-269.
12. Baskova I., Aguejouf O., Azougagh Oualane F., Zavalova L.L., Basanova A.V., Doutremepuich C. Arterial antithrombotic effect of Piyavit, the novel pharmacological preparation from the medicinal leech, and of its components prostanoids and enzyme destabilase. Thromb. Res. 77:1995;483-492.
13. Lee A., O'Rourke J., De Ungria M.C., Robertson B., Daskalopoulos G., Dixon M.F. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology. 112:1997;1386-1397.
14. Cardinal D., Flowers R. The electronic aggregometer: a novel device for assessing platelet behavior in blood. J. Pharmacol. Methods. 3:1980;135-138.
15. Mendall M.A., Goggin P.M., Molineaux N., Levy J., Toosy T., Strachan D.et al. Relation of Helicobacter pylori infection and coronary heart disease. Br. Heart J. 71:1994;437-439.
16. Regenström J., Jovinge S., Båvenholm P., Ericsson C.-G., De Faire U., Hamsten A.et al. Helicobacter pylori seropositivity is not associated with inflammatory parameters, lipid concentration and degree of coronary artery disease. J. Intern. Med. 243:1998;109-113.
17. Wald N.J., Law M.R., Morris J.K., Bagnall A.M. Helicobacter pylori infection and mortality from ischaemic heart disease: negative result from a large, prospective study. BMJ. 315:1997;1199-1201.
18. Markus H.S., Mendall M.A. Helicobacter pylori infection: a risk factor for ischaemic cerebrovascular disease and carotid atheroma. J. Neurol. Neurosurg. Psychiatry. 64:1998;104-107.
19. Blasi F., Denti F., Erba M., Cosentini R., Raccanelli R., Rinaldi A.et al. Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J. Clin. Microbiol. 34:1996;2766-2769.
20. Aguejouf O., Belougne-Malfatti E., Doutremepuich F., Belon P., Doutremepuich C. Thromboembolic complications several days after a single-dose administration of aspirin. Thromb. Res. 89:1998;123-127.
21. Elizalde J.I., Gomez J., Panés J., Lozano M., Casadevail M., Ramírez J.et al. Platelet activation in mice and human Helicobacter pylori infection. J. Clin. Invest. 100:1997;996-1005.
22. Beardshall K., Moss S., Gill J.et al. Suppression of Helicobacter pylori reduces gastrin releasing peptide stimulated gastrin release in duodenal ulcer patients. Gut. 33:1992;601-603.
23. Patel P., Mendall M.A., Carrington D., Strachan D.P., Leatham E., Molineaux N.et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ. 311:1995;711-714.
24. Parente F., Maconi G., Imbesi V., Sangaletti O., Poggio M., Rossi E.et al. Helicobacter pylori infection and coagulation in healthy people. BMJ. 314:1997;1318-1319.
25. Miragliotta G., Del Prete R., Mosca A. Helicobacter pylori and coronary heart disease. Lancet. 344:1994;751.
26. 13C-Urea Breath Test does not alter fibrinogen and acute phase response markers. Thromb. Res. 97:2000;411-420.